151 related articles for article (PubMed ID: 10479903)
1. Utility and complications of permanent venous access devices (PVAD) in oncological treatments. Follow-up of 100 cases.
Groebli Y; Wutrich P; Safa M; Tschantz P; Callewaert G; Piguet D
Panminerva Med; 1999 Jun; 41(2):89-92. PubMed ID: 10479903
[TBL] [Abstract][Full Text] [Related]
2. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.
Araújo C; Silva JP; Antunes P; Fernandes JM; Dias C; Pereira H; Dias T; Fougo JL
Eur J Surg Oncol; 2008 Feb; 34(2):222-6. PubMed ID: 17566692
[TBL] [Abstract][Full Text] [Related]
3. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma].
Hoareau-Gruchet F; Rtail R; Sulaj H; Khirnetkina A; Reyt E; Righini CA
Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):43-52. PubMed ID: 19324328
[TBL] [Abstract][Full Text] [Related]
4. Long-term complications in totally implantable venous access devices: randomized study comparing subclavian and internal jugular vein puncture.
Ribeiro RC; Abib SC; Aguiar AS; Schettini ST
Pediatr Blood Cancer; 2012 Feb; 58(2):274-7. PubMed ID: 21674765
[TBL] [Abstract][Full Text] [Related]
5. Totally implantable venous access port systems and risk factors for complications: a one-year prospective study in a cancer centre.
Narducci F; Jean-Laurent M; Boulanger L; El Bédoui S; Mallet Y; Houpeau JL; Hamdani A; Penel N; Fournier C
Eur J Surg Oncol; 2011 Oct; 37(10):913-8. PubMed ID: 21831566
[TBL] [Abstract][Full Text] [Related]
6. [Totally implantable venous access systems. Analysis of complications].
D'Angelo F; Ramacciato G; Caramitti A; Aurello P; Lauro S; Bordin F; Della Casa U
Minerva Chir; 1997; 52(7-8):937-42. PubMed ID: 9411296
[TBL] [Abstract][Full Text] [Related]
7. [Complications of central venous access devices: outcome analysis of 2359 implantations].
Stein M; Wagner RH
Dtsch Med Wochenschr; 2005 May; 130(18):1129-32. PubMed ID: 15856394
[TBL] [Abstract][Full Text] [Related]
8. Totally implanted device for long-term intravenous chemotherapy: experience in 123 adult patients with solid neoplasms.
Puig-la Calle J; López Sánchez S; Piedrafita Serra E; Allende Honorato L; Artigas Raventós V; Puig la Calle J
J Surg Oncol; 1996 Aug; 62(4):273-8. PubMed ID: 8691841
[TBL] [Abstract][Full Text] [Related]
9. The fate of 100 prolonged venous access devices.
Hayward SR; Ledgerwood AM; Lucas CE
Am Surg; 1990 Sep; 56(9):515-9. PubMed ID: 2393188
[TBL] [Abstract][Full Text] [Related]
10. Ionic implantation of silicone chronic venous access devices does not alter thrombotic complications: a double-blinded, randomized clinical trial.
Frank JL; Garb JL; Halla B; Reed WP
Surgery; 2001 May; 129(5):547-51. PubMed ID: 11331446
[TBL] [Abstract][Full Text] [Related]
11. Peripheral infusion ports for central venous access in patients with gynecologic malignancies.
Cunningham MJ; Collins MB; Kredentser DC; Malfetano JH
Gynecol Oncol; 1996 Mar; 60(3):397-9. PubMed ID: 8774645
[TBL] [Abstract][Full Text] [Related]
12. Implantable device for venous access.
Leclerc YE; Loutfi A
Can J Surg; 1987 Mar; 30(2):127-9. PubMed ID: 3828909
[TBL] [Abstract][Full Text] [Related]
13. [Cephalic vein access for implantable venous access devices. Technique and long-term follow-up].
Conessa C; Talfer S; Herve S; Chollet O; Poncet JL
Rev Laryngol Otol Rhinol (Bord); 2002; 123(3):143-8. PubMed ID: 12577777
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of different central venous approaches for port placement and use in adult oncology patients: evidence from a randomized three-arm trial.
Biffi R; Pozzi S; Bonomo G; Della Vigna P; Monfardini L; Radice D; Rotmensz N; Zampino MG; Fazio N; Orsi F
Ann Surg Oncol; 2014 Nov; 21(12):3725-31. PubMed ID: 24841352
[TBL] [Abstract][Full Text] [Related]
15. [Implantable devices for permanent venous access. A single-center prospective study comparing an AIDS population with a control population (80 cases)].
Johanet H; Saliou C; Marmuse JP; Benhamou G; Charleux H
Ann Chir; 1991; 45(6):497-501. PubMed ID: 1929166
[TBL] [Abstract][Full Text] [Related]
16. Experience of anesthesiologists with percutaneous nonangiographic venous access.
Chen PT; Sung CS; Wang CC; Chan KH; Chang WK; Hsu WH
J Clin Anesth; 2007 Dec; 19(8):609-15. PubMed ID: 18083475
[TBL] [Abstract][Full Text] [Related]
17. [Implanted venous access system in oncology. Review of 296 cases].
Guenier C; Nogaret JM; Ferreira J; Lorent I; Pector JC
Ann Chir; 1990; 44(5):388-91. PubMed ID: 2372203
[TBL] [Abstract][Full Text] [Related]
18. Use of central venous catheters for prolonged venous access in cancer chemotherapy.
Rajoor BG; Charak BS; Banavali SD; Iyer RS; Saikia TK; Gopal R; Advani SH
J Assoc Physicians India; 1990 May; 38(5):340-2. PubMed ID: 2387816
[TBL] [Abstract][Full Text] [Related]
19. [Totally implantable venous access ports by cephalic vein cut-down for patients receiving chemotherapy].
Ayadi S; Ksantini R; Maghrebi H; Daghfous A; Ayadi M; Fteriche F; Bedioui H; Chebbi F; Amous A; Jouini M; Kacem M; Mezlini A; Ben Safta Z
Tunis Med; 2011; 89(8-9):699-702. PubMed ID: 21948685
[TBL] [Abstract][Full Text] [Related]
20. [Fistulae or catheter for elderly who start hemodialysis without permanent vascular access?].
García Cortés MJ; Viedma G; Sánchez Perales MC; Borrego FJ; Borrego J; Pérez del Barrio P; Gil Cunquero JM; Liébana A; Pérez Bañasco V
Nefrologia; 2005; 25(3):307-14. PubMed ID: 16053012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
